UroGen Pharma (URGN) PT Raised to $30 at D. Boral Capital
Tweet Send to a Friend
D. Boral Capital analyst Jason Kolbert raised the price target on UroGen Pharma (NASDAQ: URGN) to $30.00 (from $25.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
